Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2601 to 2650 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin m3; ancient conserved domain protein 3. [source:refseq;acc:nm\_017623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.502\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.2\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00141\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arp2/3 complex 16 kda subunit (p16-arc) (actin-related protein 2/3 complex subunit 5). [source:swissprot;acc:o15511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 224.875\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.192\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin m4; ancient conserved domain protein 4. [source:refseq;acc:nm\_020184]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.494\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.192\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin m2; ancient conserved domain protein 2. [source:refseq;acc:nm\_017649]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.486\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.184\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tcd37 homolog; prune. [source:refseq;acc:nm\_021222]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.495\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.193\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin m1; ancient conserved domain protein 1. [source:refseq;acc:nm\_020348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.198\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial 28s ribosomal protein s22 (s22mt) (mrp-s22) (gk002). [source:swissprot;acc:p82650]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.497\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 215.799\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0014\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nefa-interacting nuclear protein nip30. [source:refseq;acc:nm\_024946]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lim homeobox transcription factor 1 alpha (lim/homeobox protein lmx1a) (lim-homeobox protein 1.1) (lmx-1.1). [source:swissprot;acc:q8te12]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial precursor proteins import receptor (translocase of outer membrane tom70). [source:swissprot;acc:o94826]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lim homeobox transcription factor 1 beta (lim/homeobox protein lmx1b) (lim-homeobox protein 1.2) (lmx-1.2). [source:swissprot;acc:o60663]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proteasome subunit beta type 2 (ec 3.4.25.1) (proteasome component c7-i) (macropain subunit c7-i) (multicatalytic endopeptidase complex subunit c7-i). [source:swissprot;acc:p49721]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor-like protein 1. [source:swissprot;acc:p40616]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor p65 (nuclear factor nf-kappa-b p65 subunit). [source:swissprot;acc:q04206]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 202.821\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 202.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00139\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor relb (i-rel). [source:swissprot;acc:q01201]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nf-kappab inhibitor alpha (major histocompatibility complex enhancer- binding protein mad3) (i-kappa-b-alpha) (ikappabalpha) (ikb-alpha). [source:swissprot;acc:p25963]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent coproporphyrinogen iii oxidase, mitochondrial precursor (ec 1.3.3.3) (coproporphyrinogenase) (coprogen oxidase) (cox). [source:swissprot;acc:p36551]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent isocitrate dehydrogenase [nadp], mitochondrial precursor (ec 1.1.1.42) (oxalosuccinate decarboxylase) (idh) (nadp+-specific icdh) (idp) (icd-m). [source:swissprot;acc:p48735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 190.166\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 190.429\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00138\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent swi/snf-related matrix-associated actin-dependent regulator of chromatin c2 isoform a; mammalian chromatin remodeling complex brg1-associated factor 170; chromatin remodeling complex baf170 subunit; swi3-like protein; swi/snf complex 170 kda subunit. [source:refseq;acc:nm\_003075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 220.024\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.722\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00137\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 9 (26s proteasome regulatory subunit p27). [source:swissprot;acc:o00233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.615\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.91\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 224.891\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 225.195\vspace{3pt}}}&\multirow{14}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00135\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 258. [source:refseq;acc:nm\_145310]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 261 (dxs6673e protein). [source:swissprot;acc:q14202]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent wilms' tumor 1-associating protein (wt1-associated protein). [source:swissprot;acc:q15007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 204.304\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.028\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-like protein 2 (actin-related protein 2). [source:swissprot;acc:o15142]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 224.891\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 225.195\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to actin-related protein 3-beta. [source:sptrembl;acc:q96bt2]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent actin-related protein 2/3 complex subunit 1a (sop2-like protein). [source:swissprot;acc:q92747]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pre-mrna cleavage complex ii protein clp1. [source:swissprot;acc:q92989]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 166.612\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 166.393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00132\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 195.635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 195.384\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00128\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 187.075\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 186.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00126\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 204.911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00125\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin viia. [source:swissprot;acc:q13402]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 220.658\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 220.386\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00123\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 b (ec 6.3.2.19) (ubiquitin-protein ligase b) (ubiquitin carrier protein b) (hr6b) (hhr6b) (e2-17 kda). [source:swissprot;acc:p23567]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 a (ec 6.3.2.19) (ubiquitin-protein ligase a) (ubiquitin carrier protein a) (hr6a) (hhr6a). [source:swissprot;acc:p49459]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent topoisomerase (dna) ii binding protein. [source:refseq;acc:nm\_007027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 194.097\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 194.328\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00119\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent acyl-coenzyme a oxidase 1, peroxisomal (ec 1.3.3.6) (palmitoyl-coa oxidase) (aox). [source:swissprot;acc:q15067]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp synthase f chain, mitochondrial (ec 3.6.3.14). [source:swissprot;acc:p56134]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tsc22-related inducible leucine zipper protein 2 (tsc-22-like protein thg-1). [source:swissprot;acc:q9y3q8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 213.169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.417\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00116\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.25\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 213.169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.417\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 213.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.874\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00114\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kh-type splicing regulatory protein (fuse binding protein 2); kh-type splicing regulatory protein (fuse-binding protein 2). [source:refseq;acc:nm\_003685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.188\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.942\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00113\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/